Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (451-460 of 759) with videos related to

Pageof 76
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.
Blood|September 30, 2006
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosisAngela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust, et al.
Blood|February 21, 2013
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approachAngela Baker, Esteban Braggio, Susanna Jacobus, et al.
Haematologica|August 23, 2023
Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myelomaPaul G Richardson, Brian G Durie, Laura Rosiñol, et al.
American Journal of Hematology|June 19, 2023
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, et al.
Blood|December 24, 2005
Clinical implication of centrosome amplification in plasma cell neoplasmWee J Chng, Greg J Ahmann, Kim Henderson, et al.
Bone Marrow Transplantation|June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosisNadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
JAMA Cardiology|August 25, 2021
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection FractionOmar F AbouEzzeddine, Daniel R Davies, Christopher G Scott, et al.
Blood Cancer Journal|December 6, 2022
Second- and third-line treatment strategies in multiple myeloma: a referral-center experienceSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings|January 4, 2011
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk scoreShaji K Kumar, Morie A Gertz, Martha Q Lacy, et al.
Pageof 76

Showing results (451-460 of 759) with videos related to

Sort By:
Pageof 76
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.
Blood|September 30, 2006
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosisAngela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust, et al.
Blood|February 21, 2013
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approachAngela Baker, Esteban Braggio, Susanna Jacobus, et al.
Haematologica|August 23, 2023
Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myelomaPaul G Richardson, Brian G Durie, Laura Rosiñol, et al.
American Journal of Hematology|June 19, 2023
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, et al.
Blood|December 24, 2005
Clinical implication of centrosome amplification in plasma cell neoplasmWee J Chng, Greg J Ahmann, Kim Henderson, et al.
Bone Marrow Transplantation|June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosisNadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
JAMA Cardiology|August 25, 2021
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection FractionOmar F AbouEzzeddine, Daniel R Davies, Christopher G Scott, et al.
Blood Cancer Journal|December 6, 2022
Second- and third-line treatment strategies in multiple myeloma: a referral-center experienceSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Mayo Clinic Proceedings|January 4, 2011
Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk scoreShaji K Kumar, Morie A Gertz, Martha Q Lacy, et al.
Pageof 76